Where Medtronic makes its money after the Covidien acquisition
Medtronic has been about more than pacemakers for a long time, but that's more true than ever thanks to the company's acquisition of Covidien.
The medical-device giant on Tuesday released its first earnings report that includes financial results from Covidien, and it also broke out how its revenue mix changed as a combined company.
As a standalone business, Medtronic's cardiac and vascular business — a unit that includes bread-and-butter heart devices like defibrillators and heart valves —…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Katharine Grayson Source Type: news
More News: Biotechnology | Cardiology | Health | Health Management | Heart | Heart Valve Disease | Heart Valves | Medical Devices | Mergers and Aquisitions